IL2 and tuberculosis: Combined with a fusion protein WH121, it helped to evoke more robust antigen-specific Th1-type immune responses and generate more IL-2-positive multifunctional T cells than did MTO or Mv, thus providing the same protective efficacy against TB as the BCG vaccine.